The worst prognosis of patients with BMI > 29 kg/m2 appears to be related to an insufficient inhibition of aromatase and, therefore, not simply to a condition of obesity. The gene discussed is CYP19A1; the disease is obesity due to melanocortin 4 receptor deficiency.